Isatuximab plus carfilzomib and dexamethasone vs. carfilzomib and dexamethasone in relapsed/refractory multiple myeloma (ikema): interim analysis of a phase 3, randomized, open-label study
Turgut, M., Moreau, P., Dimopoulos, M., Mikhael, J., Yong, K., Capra, M., Facon, T., Hajek, R., Spicka, I., Risse, M., Asset, G., Macé, S., Martin, T.Volume:
42
Journal:
Hematology, Transfusion and Cell Therapy
DOI:
10.1016/j.htct.2020.09.093
Date:
October, 2020
File:
PDF, 41 KB
2020